Medicinal Plant Diversity
Medicinal plant diversity refers to the wide range of plant species that human communities use, or have potential to use, as sources of medicines. It encompasses the taxonomic, geographic, and chemical breadth of the world's medicinal flora and underlies both traditional health systems and the search for new drug leads.
Definition
Medicinal plant diversity is the variety of plant species, and the chemical diversity of the compounds they contain, that are used or investigated as sources of therapeutic agents.
Scope
The topic covers the number and distribution of plant species used medicinally, the chemical diversity of their secondary metabolites, the relationship between biodiversity and drug discovery, and the conservation pressures that affect medicinal plant resources. It is framed as a reference topic describing the resource base of medicinal plants, not as guidance on using any particular species.
Core questions
- How many plant species are used medicinally, and where are they concentrated?
- What chemical diversity do medicinal plants contribute as a source of drug leads?
- How does the conservation status of medicinal plants affect their availability?
Key concepts
- Medicinal flora
- Secondary metabolite (chemical) diversity
- Biodiversity and bioprospecting
- Endemism and geographic distribution
- Conservation and sustainable harvesting
- Natural products as drug leads
Mechanisms
The therapeutic interest of medicinal plant diversity rests largely on secondary metabolites, structurally varied compounds such as alkaloids, terpenoids, and phenolics that plants produce for ecological functions and that can interact with human biological targets. The breadth of plant taxa, and the distinct biosynthetic pathways within them, generate a large chemical space that has historically yielded numerous drug leads; reviews of natural-product drug discovery document how often plant-derived structures enter the pharmacopoeia.
Clinical relevance
The diversity of medicinal plants is the resource base from which many established drugs and candidate compounds have come, and it shapes which remedies are locally available in traditional health systems. The topic describes this resource and its scientific significance and is not a basis for individual diagnostic or treatment decisions.
Epidemiology
Estimates of the number of plant species used medicinally vary by source and definition, but reviews consistently describe many thousands of species in use worldwide, with notable concentrations in biodiverse regions; precise global counts remain uncertain.
Evidence & guidelines
Reviews of natural-product drug discovery (Fabricant & Farnsworth; Newman & Cragg; Cragg & Newman) document the contribution of plant chemical diversity to medicine. The WHO Traditional Medicine Strategy and conservation frameworks address sustainable use of medicinal plant resources.
History
Awareness of medicinal plant diversity is as old as materia medica, but its systematic study grew with modern botanical surveys, natural-product chemistry, and bioprospecting programmes in the twentieth century, which catalogued species and isolated their active compounds, while conservation concerns later highlighted the vulnerability of this resource.
Key figures
- Norman Farnsworth
- Gordon Cragg
- David Newman
Related topics
Seminal works
- fabricant-farnsworth-2001
- newman-cragg-2020
Frequently asked questions
- How many plant species are used as medicines?
- Reviews report many thousands of species in medicinal use worldwide, but the exact number depends on how 'medicinal use' is defined and on the completeness of ethnobotanical records, so published estimates differ.
- Why does plant diversity matter for drug discovery?
- Different plant taxa produce structurally diverse secondary metabolites, creating a large chemical space to screen for biological activity. Analyses of natural-product drug discovery show that plant-derived structures have repeatedly become, or inspired, useful medicines.